These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 23195780)
1. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study). Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780 [TBL] [Abstract][Full Text] [Related]
2. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)]. Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148 [TBL] [Abstract][Full Text] [Related]
3. High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study). Hannoun-Levi JM; Ortholan C; Resbeut M; Teissier E; Ronchin P; Cowen D; Zaccariotto A; Bénézery K; François E; Salem N; Ellis S; Azria D; Gerard JP Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):712-20. PubMed ID: 20619552 [TBL] [Abstract][Full Text] [Related]
4. Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study). Ortholan C; Resbeut M; Hannoun-Levi JM; Teissier E; Gerard JP; Ronchin P; Zaccariotto A; Minsat M; Benezery K; François E; Salem N; Ellis S; Azria D; Champetier C; Gross E; Cowen D Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1988-95. PubMed ID: 21570207 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma. Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244 [TBL] [Abstract][Full Text] [Related]
6. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy. Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590 [TBL] [Abstract][Full Text] [Related]
7. Definitive radiotherapy for squamous cell carcinoma of the anal canal. Rabbani AN; Zlotecki RA; Kirwan J; George TJ; Morris CG; Rout WR; Mendenhall WM Am J Clin Oncol; 2010 Feb; 33(1):47-51. PubMed ID: 19704368 [TBL] [Abstract][Full Text] [Related]
8. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058 [TBL] [Abstract][Full Text] [Related]
9. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers. Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Chapet O; Gerard JP; Riche B; Alessio A; Mornex F; Romestaing P Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1316-24. PubMed ID: 16169674 [TBL] [Abstract][Full Text] [Related]
11. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542 [TBL] [Abstract][Full Text] [Related]
12. Interstitial high-dose rate brachytherapy as boost for anal canal cancer. Falk AT; Claren A; Benezery K; François E; Gautier M; Gerard JP; Hannoun-Levi JM Radiat Oncol; 2014 Nov; 9():240. PubMed ID: 25377886 [TBL] [Abstract][Full Text] [Related]
14. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Huart J; Pène F; Schlienger M Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1259-73. PubMed ID: 12873670 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
16. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Gerard JP; Ayzac L; Hun D; Romestaing P; Coquard R; Ardiet JM; Mornex F Radiother Oncol; 1998 Mar; 46(3):249-56. PubMed ID: 9572617 [TBL] [Abstract][Full Text] [Related]
17. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483 [TBL] [Abstract][Full Text] [Related]
18. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch]. Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281 [TBL] [Abstract][Full Text] [Related]
19. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894 [TBL] [Abstract][Full Text] [Related]